HLA-DQ RATHER THAN HLA-DR REGION MIGHT BE INVOLVED IN DOMINANT NONSUSCEPTIBILITY TO DIABETES

被引:52
作者
STERKERS, G
ZELISZEWSKI, D
CHAUSSEE, AM
DESCHAMPS, I
FONT, MP
FREIDEL, C
HORS, J
BETUEL, H
DAUSSET, J
LEVY, JP
机构
[1] HOP COCHIN, CNRS,UA 628,INSERM,U152, IMMUNOL & VIROL TUMEURS LAB, F-75674 PARIS 14, FRANCE
[2] HOP ST LOUIS, CTR HAYEM,INSERM,U93,IMMUNOGENET TRANSPLANTAT LAB, F-75475 PARIS 10, FRANCE
[3] HOP HEROLD, F-75935 PARIS 19, FRANCE
[4] CTR REG TRANSFUS SANGUINE LYON, F-69007 LYON, FRANCE
关键词
D O I
10.1073/pnas.85.17.6473
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Since HLA-DRw15 (a subdivision of the HLA-DR2 specificity previously called DR2 long) is associated with dominant nonsusceptibility to insulin-dependent diabetes mellitus (IDDM), while HLA-DRw16 (another subdivision of HLA-DR2, previously called DR2 short) is positively associated with the disease, we looked for particular characteristics of HLA products encoded by the DR2 haplotypes of IDDM patients. The results show the following: (i) HLA-DQ molecules of HLA-DRw15-positive IDDM patients are different from those of HLA-DRw15-positive controls, suggesting that the HLA-DQ gene of DRw15 haplotypes is involved in a protective effect. (ii) HLA-DR and -DQ products of DRw16-positive IDDM are functionally indistinguishable from those of HLA-DRw16-positive controls. Furthermore, our data provide evidence that the residue at position 57 on the DQ.beta. chain could play a crucial biological role in antigen presentation to T cells as far as the DRw16 haplotype is concerned. This observation fits with the recent observation of correlation between DQ.beta. allelic polymorphism at position 57 and both susceptibility and resistance to IDDM.
引用
收藏
页码:6473 / 6477
页数:5
相关论文
共 26 条
  • [1] INSULIN DEPENDENT DIABETES - ASSOCIATED HLA-D REGION ENCODED DETERMINANTS
    BACH, FH
    RICH, SS
    BARBOSA, J
    SEGALL, M
    [J]. HUMAN IMMUNOLOGY, 1985, 12 (02) : 59 - 64
  • [2] BARBOSA J, 1982, CLIN GENET, V21, P25
  • [3] A POSSIBLE NEW HLA-DR ALLELE
    BETUEL, H
    GEBUHRER, L
    LAMBERT, J
    FREIDEL, AC
    FARRE, A
    [J]. HUMAN IMMUNOLOGY, 1983, 8 (03) : 227 - 237
  • [4] BOHME J, 1986, J IMMUNOL, V137, P941
  • [5] INSITU CHARACTERIZATION OF AUTOIMMUNE PHENOMENA AND EXPRESSION OF HLA MOLECULES IN THE PANCREAS IN DIABETIC INSULITIS
    BOTTAZZO, GF
    DEAN, BM
    MCNALLY, JM
    MACKAY, EH
    SWIFT, PGF
    GAMBLE, DR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (06) : 353 - 360
  • [6] BOTTAZZO GF, 1983, LANCET, V2, P1115
  • [7] CLASS-II HLA-DC BETA-CHAIN DNA RESTRICTION FRAGMENTS DIFFERENTIATE AMONG HLA-DR2 INDIVIDUALS IN INSULIN-DEPENDENT DIABETES AND MULTIPLE-SCLEROSIS
    COHEN, D
    COHEN, O
    MARCADET, A
    MASSART, C
    LATHROP, M
    DESCHAMPS, I
    HORS, J
    SCHULLER, E
    DAUSSET, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (06): : 1774 - 1778
  • [8] HLA-DR2-ASSOCIATED DW SUBTYPES CORRELATE WITH RFLP CLUSTERS - MOST DR2 IDDM PATIENTS BELONG TO ONE OF THESE CLUSTERS
    COHEN, N
    BRAUTBAR, C
    FONT, MP
    DAUSSET, J
    COHEN, D
    [J]. IMMUNOGENETICS, 1986, 23 (02) : 84 - 89
  • [9] A SYSTEMATIC STUDY OF HLA CLASS-II-BETA DNA RESTRICTION FRAGMENTS IN INSULIN-DEPENDENT DIABETES-MELLITUS
    COHENHAGUENAUER, O
    ROBBINS, E
    MASSART, C
    BUSSON, M
    DESCHAMPS, I
    HORS, J
    LALOUEL, JM
    DAUSSET, J
    COHEN, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (10) : 3335 - 3339
  • [10] HLA-DR2, HLA-DR5, AND HLA-DRW6 ASSOCIATED DW SUBTYPES CORRELATE WITH HLA-DR-BETA AND HLA-DQ-BETA RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS
    FONT, MP
    GEBUHRER, L
    BETUEL, H
    FREIDEL, C
    DAUSSET, J
    COHEN, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (10) : 3361 - 3365